Trial intelligence / Profile preview

Suvorexant for Insomnia and Fatigue in Multiple Sclerosis

NCT03110315Phase 4Completed

Sponsor
Theodore R. Brown
Start
Mar 2017
Primary completion
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of suvorexant in Insomnia, fatigue, sponsored by Theodore R. Brown. Started Mar 2017; status: completed.

02

Drugs

suvorexant
03

Conditions

Insomniafatigue

Beyond the preview

Go deeper on NCT03110315.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03110315.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call